Belgium· BE-AMP-SAM275432-00

Emselex 7.5 mg

A darifenacin product containing darifenacin hydrobromide, registered in Belgium by pharmaand. The same ATC class is registered in 15 of our 19 countries.

ATC G04BD10

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about darifenacin hydrobromideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Darifenacin is registered in 15 of 19 countries.

Countries holding a registration under ATC G04BD10 (darifenacin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
9 of them publish a price we can compare per daily dose

Search darifenacin products by name

Darifenacin · ATC G04BD10

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of darifenacin costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Darifenacin · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.84

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Darifenacin Hydrobromide
Manufacturer: pharmaand
Country: Belgium (BE)
ATC code: G04BD10
ATC class: Darifenacin
Defined daily dose: 7.5 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 3

1 priced

be_apb
2191013
EUR 57.1
be_apb
0785527
be_apb
2190981

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

246 interactions on record for darifenacin.

Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check darifenacin against other medicines How interaction checks work

Darifenacin · interactions on record

246 records

13 severe
155 moderate
1 minor
49 info

Most severe, free to view

Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe
EliglustatA16AX10severe
Potassium chlorideB05XA01severe

28 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Darifenacin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All darifenacin products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

Germany · Darifenacin Aristo
Spain · Darifenacina Aristo
United Kingdom (Northern Ireland) · Darifenacin Aristo
Iceland · Emselex
Liechtenstein · Emselex
Netherlands · Darifenacine Aristo
Norway · Emselex
Portugal · Darifenacina Aristo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/317e8dae-b4e8-449d-964b-0610fed7da07
GET /v1/drugs/317e8dae-b4e8-449d-964b-0610fed7da07?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Emselex 7.5 mg",
  "name_fr": "Emselex 7.5 mg",
  "name_nl": "Emselex 7.5 mg",
  "amp_code": "SAM275432-00",
  "strengths": [
    "7.5000",
    "7.5000",
    "7.5000"
  ],
  "pack_count": 14,
  "substances": [
    "Darifenacin Hydrobromide",
    "Darifenacin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Darifenacin",
  "authorisation_numbers": [
    "EU/1/04/294/001",
    "EU/1/04/294/002",
    "EU/1/04/294/003",
    "EU/1/04/294/004",
    "EU/1/04/294/005",
    "EU/1/04/294/006",
    "EU/1/04/294/013",
    "EU/1/04/294/015",
    "EU/1/04/294/017",
    "EU/1/04/294/016",
    "EU/1/04/294/019",
    "EU/1/04/294/018",
    "EU/1/04/294/020",
    "EU/1/04/294/027"
  ]
}

API reference MCP server Plans

See everything about darifenacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console